UFF
NPTN

USA Financial Formulas’s NEOPHOTONICS CORP NPTN Stock Holding History

USA Financial Formulas’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,455
Closed -$93K – 372
2020
Q2 		$93K Buy
+10,455
New +$90.1K 0.07% 73

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

USA Financial Formulas's NPTN Position: Q3 2020 in Review

USA Financial Formulas sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 10,455 shares — an estimated $93K sold.

USA Financial Formulas first reported a position in NPTN in Q2 2020 and held it in 1 quarter. The position peaked at $93K in Q2 2020. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

  • USA Financial Formulas reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
  • USA Financial Formulas sold 10,455 NEOPHOTONICS CORP shares in Q3 2020, an estimated $93K.
  • USA Financial Formulas first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 1 quarter.
  • USA Financial Formulas's NEOPHOTONICS CORP position peaked at $93K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on USA Financial Formulas's 13F filing for Q3 2020, filed 9 Oct 2020.